Commentary on: Is It Worth Using Botulinum Toxin Injections for the Management of Mild to Moderate Blepharoptosis?
Aesthet Surg J
.
2022 Dec 14;42(12):1382-1384.
doi: 10.1093/asj/sjac161.
Author
Salvatore J Pacella
1
Affiliation
1
Division of Plastic and Reconstructive Surgery, Scripps MD Anderson Cancer Center, La Jolla, CA, USA.
PMID:
35723540
DOI:
10.1093/asj/sjac161
No abstract available
Publication types
Editorial
Comment
MeSH terms
Blepharoptosis* / drug therapy
Botulinum Toxins, Type A* / administration & dosage
Botulinum Toxins, Type A* / adverse effects
Humans
Substances
Botulinum Toxins, Type A